Complete remission in a patient with sinonasal squamous cell carcinoma receiving neoadjuvant tislelizumab plus chemotherapy: a case report

Sinonasal squamous cell carcinoma (SNSCC) is the most common, high-aggressive sinonasal malignancies that have remained relatively stable poor outcomes over the past decade. As a first-line treatment for SNSCC, surgery plus adjuvant radiotherapy is recommended. However, complete surgical resection m...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Fang Chen, Hongzheng Zhang, Yonghe Li, Tingfeng Liang, Tao Zhang
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Frontiers Media S.A. 2024-07-01
Serie:	Frontiers in Immunology
Ämnen:	sinonasal squamous cell carcinoma tislelizumab immune checkpoint inhibitor immunotherapy pathological complete response
Länkar:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1414529/full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!